Market Value1,635,018,721
Total Holdings63
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
JBIO / Jade Biosciences, Inc.
INSM / Insmed Incorporated
BSX / Boston Scientific Corporation
ESTA / Establishment Labs Holdings Inc.
IDYA / IDEAYA Biosciences, Inc.
ROIV / Roivant Sciences Ltd.
ACAD / ACADIA Pharmaceuticals Inc. Call
SRPT / Sarepta Therapeutics, Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
ALNY / Alnylam Pharmaceuticals, Inc.
SLNO / Soleno Therapeutics, Inc. Put
ELVN / Enliven Therapeutics, Inc.
MDT / Medtronic plc
KURA / Kura Oncology, Inc.
BMY / Bristol-Myers Squibb Company
PEN / Penumbra, Inc.
ERAS / Erasca, Inc.
AVTE / Aerovate Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
INCY / Incyte Corporation
EWTX / Edgewise Therapeutics, Inc. Put
SYK / Stryker Corporation
VIR / Vir Biotechnology, Inc.
DHR / Danaher Corporation
BOLT / Bolt Biotherapeutics, Inc.
DXCM / DexCom, Inc.
RCUS / Arcus Biosciences, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
IKNA / Ikena Oncology, Inc.
AVBP / ArriVent BioPharma, Inc.
PTCT / PTC Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
RAPP / Rapport Therapeutics, Inc.
UTHR / United Therapeutics Corporation
ABBV / AbbVie Inc.
NTRA / Natera, Inc.
MRUS / Merus N.V.
GILD / Gilead Sciences, Inc.
PRAX / Praxis Precision Medicines, Inc.
LLY / Eli Lilly and Company
ANAB / AnaptysBio, Inc.
ROIV / Roivant Sciences Ltd. Call
INZY / Inozyme Pharma, Inc.
QURE / uniQure N.V.
IMNM / Immunome, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
MTSR / Metsera, Inc.
EXAS / Exact Sciences Corporation
PHVS / Pharvaris N.V.
DYN / Dyne Therapeutics, Inc.
SUPN / Supernus Pharmaceuticals, Inc.
IRON / Disc Medicine, Inc.
SVRA / Savara Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
SNDX / Syndax Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
INBX / Inhibrx Biosciences, Inc.
REPL / Replimune Group, Inc.
BBIO / BridgeBio Pharma, Inc.
RNA / Avidity Biosciences, Inc.
BIOA / BioAge Labs, Inc.
REPL / Replimune Group, Inc. Put
IWM / iShares Trust - iShares Russell 2000 ETF Put
IMTX / Immatics N.V.
APGE / Apogee Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc. Put
IBB / iShares Trust - iShares Biotechnology ETF Put
COGT / Cogent Biosciences, Inc.
COGT / Cogent Biosciences, Inc. Call
CDTX / Cidara Therapeutics, Inc.
CDTX / Cidara Therapeutics, Inc. Call
NXTC / NextCure, Inc.
WVE / Wave Life Sciences Ltd.
BOLT / Bolt Biotherapeutics, Inc.
SMMT / Summit Therapeutics Inc. Call